eye problems with glp 1 GLP-1 Drugs and Ocular Disease: Between Neuroprotection and Risk Semaglutide Tied to Increased Risk

Exenatide is the worlds first GLP-RA product

A comprehensive analysis of 43,365 individuals from two US healthcare databases indicated that GLP-1 RAs do not elevate the risk of pulmonary aspiration during upper gastrointestinal endoscopy in patients with T2DM when compared to SGLT-2 inhibitors, yielding a pooled risk ratio of 0.98 (95% CI, 0.73 to 1.31) among GLP-1 RA users

Effects on Stroke Stroke is the second leading cause of death and the leading cause of disability worldwide

How is my health information stored, and who has access to it

6 Need-to-Know Facts When Considering GLP-1s 1

Their ability to effectively present the plaintiffs claims and hold the drug manufacturers accountable could have far-reaching implications for the pharmaceutical industry and patient safety standards